PURE Bioscience, Inc. (OTCMKTS:PURE) Short Interest Update

PURE Bioscience, Inc. (OTCMKTS:PUREGet Rating) was the recipient of a significant growth in short interest in May. As of May 31st, there was short interest totalling 44,300 shares, a growth of 23.7% from the May 15th total of 35,800 shares. Based on an average daily volume of 48,900 shares, the short-interest ratio is currently 0.9 days.

Shares of OTCMKTS:PURE opened at $0.20 on Friday. The company has a 50 day moving average of $0.19 and a 200 day moving average of $0.21. PURE Bioscience has a 12 month low of $0.15 and a 12 month high of $0.50.

PURE Bioscience (OTCMKTS:PUREGet Rating) last issued its quarterly earnings data on Tuesday, March 15th. The company reported ($0.01) EPS for the quarter. The firm had revenue of $0.42 million for the quarter. PURE Bioscience had a negative net margin of 131.59% and a negative return on equity of 131.39%.

About PURE Bioscience (Get Rating)

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.

Recommended Stories

Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.